Cell lines overexpressing EMP1 presented mitochondrial-dependent apoptosis and VEGF-C-mediated tumor angiogenesis inhibition in a colorectal and prostate cancer study [68, 70]. The gene discussed is VEGFC; the disease is prostate carcinoma.